Description:
Produced by the Centers for Disease Control and Prevention, the CDC Human Influenza Virus Real-time RT-PCR Diagnostic Panel Kit Suite is a comprehensive set of tools designed for the accurate and timely detection and diagnosis of human influenza viruses.
This suite comprises four distinct yet complementary kits – Influenza A/B Typing kit, Influenza A Subtyping kit, Influenza B Lineage Genotyping kit, and Influenza A/HS Subtyping Kit. These have been engineered to provide comprehensive laboratory testing from patient samples with utmost precision.
Main Uses:
The primary use of these kits is to facilitate prompt identification of influenza strains in suspected human samples. By accurately ascertaining the type (A or B), subtyping (for type A), lineage identification (for type B), and hemagglutinin subtype determination (for type A) of the influenza virus, these kits enable healthcare providers to tailor patient treatment accordingly.
Benefits:
Speed and accuracy are the hallmarks of these kits. They are designed to deliver quick results, helping healthcare professionals make effective, time-sensitive decisions about patient care and treatment. Integrated within the standard RT-PCR workflow, these panel kits enhance laboratory productivity and efficiency.
Moreover, identification of the influenza virus type not only aids in therapeutic decisions but also helps in surveillance and outbreak control, enhancing public health measures.
The CDC Human Influenza Virus Real-time RT-PCR Diagnostic Panel Kit Suite is key to diagnosing, monitoring, and understanding the influenza virus. By providing accurate and immediate results, it supports the fight against the ever-evolving threat of influenza.